Subject: Retatrutide Research Update: GLP-1 Trends Retatrutide continues to stand out as one of the most closely watched metabolic research compounds in the current peptide landscape. In recent trend monitoring, retatrutide showed strong year-over-year search growth and continued week-over-week momentum,…
Are Peptides Legal Again After the 2026 FDA Ruling? If you’ve been following the peptide space, you probably saw the news: on April 15, 2026, the FDA removed 12 peptides — including BPC-157 and TB-500 — from the Category 2…
On April 15, 2026, the FDA made one of the most significant regulatory moves in the peptide space in years: they removed 12 peptides — including BPC-157, TB-500, and Semax — from the Category 2 restricted substances list. If you’ve…
A comprehensive research-based FAQ on BPC-157 side effects, covering what preclinical data shows, common questions from the research community, and important safety context.
BPC-157 oral vs injectable — which route shows better bioavailability? Learn the research differences, stability, absorption, and GI-specific effects.
Everything Canadian researchers need to know about BPC-157 (Body Protection Compound 157): mechanism of action, wellness applications, reconstitution, storage, safety considerations, and regulatory status in Canada.
New to peptides? Start here. A comprehensive guide covering what peptides are, how they work, what the research says, and how to evaluate suppliers. Written for Canadians.
Complete guide for Canadian researchers on CJC-1295 peptides, covering DAC vs no-DAC differences, wellness applications, dosing protocols, storage guidelines, and Canadian regulatory considerations.
What Is GHK-Cu? GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring copper peptide complex found in human blood, saliva, and urine. First isolated in 1973 by Dr. Loren Pickart, this tripeptide has become one of the most researched peptides for skin…
Tirzepatide has become one of the most talked-about wellness peptides in recent years. Originally studied for its dual action on GLP-1 and GIP receptors, this compound has generated significant interest in metabolic research. If you’re a Canadian researcher looking to…